Emergent BioSolutions to Participate in Investor Conferences
Emergent BioSolutions (NYSE: EBS) will participate in several upcoming investor conferences, showcasing its commitment to growth and communication with stakeholders.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Emergent BioSolutions (NYSE: EBS) will participate in several upcoming investor conferences, showcasing its commitment to growth and communication with stakeholders. Key dates include:
- Jefferies Inaugural Global Plasma Summit on March 11, 2021, at 12:50 PM EST.
- KeyBanc Life Sciences & MedTech Investor Forum on March 24, 2021, at 1:15 PM EST.
- Chardan 4th Annual Manufacturing Summit on April 26-27, 2021, with updated details on the Emergent website.
- Truist 7th Annual Life Sciences Summit on May 4-5, 2021, with presentation details to be announced.
These events will likely discuss recent developments and financial guidance.
Details
News Market Reaction – EBS
The recorded move for EBS in the trading session of this news was +6.46%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:
- Jefferies Inaugural Global Plasma Summit
March 11, 2021
Company fireside chat scheduled at 12:50 pm EST - KeyBanc Life Sciences & MedTech Investor Forum
March 24, 2021
Company fireside chat scheduled at 1:15 pm EST
- Chardan 4th Annual Manufacturing Summit
April 26-27, 2021
Fireside chat date and time will be updated on the Emergent website as the information becomes available.
- Truist 7th Annual Life Sciences Summit
May 4-5, 2021
Presentation date and time will be updated on the Emergent website as the information becomes available.
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.
About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com
Media Contact:
Nina DeLorenzo
SVP, Global Communications & Public Affairs
mediarelations@ebsi.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.